Posaconazole Plasma Monitoring in Immunocompromised Children

J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):389-392. doi: 10.1093/jpids/piw087.

Abstract

Plasma posaconazole exposure was assessed in 13 children who underwent a hematopoietic stem cell transplant. The median dosage was 12.5 mg/kg per day, divided into 3 doses. Of these 13 patients, 46.2% (6) and 30.8% (4) achieved concentrations higher than 0.7 and 1.25 mg/L, respectively. In children at high risk, a higher dosage might be needed to achieve target concentrations.

Keywords: children; monitoring; posaconazole.

MeSH terms

  • Child
  • Child, Preschool
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunocompromised Host*
  • Infant
  • Male
  • Retrospective Studies
  • Triazoles / administration & dosage
  • Triazoles / blood*

Substances

  • Triazoles
  • posaconazole